Fundraising Fox

Iyengar Capital Partners

Venture capital

Clayton · Seed–Series B · 16 people tracked

Find your way into Iyengar Capital Partners

501 people in our graph share verified history with the Iyengar Capital Partners team — schools, employers, funds. One of them is your warm intro.

Evans Grenierunlockedknows Clayton Gentsch · together at Raymond James (overlapped)
×2knows the team · via University of Pennsylvania School of Medicine
×5knows the team · via RBC Capital Markets
×3knows the team · via Washington University in St. Louis - Olin Business School
knows the team · via Raymond James
Fox Verdict
Sign up to see your fit

Investment thesis

Iyengar Capital targets clinical development stage medical device companies, an area it views as offering higher risk and return than private equity or growth equity investing. The team brings deep clinical, healthcare, and physician experience, allowing it to identify significant upside while mitigating risk during the clinical stage. It positions itself as a partner of choice for leading clinical-stage device companies and emphasizes that its physician backgrounds and repeated experience navigating the clinical development journey differentiate it from other investors who lack such hands-on clinical expertise.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Series B
HQ
Clayton, Missouri, US
Instruments
Equity
Founded
2022
Tracked investments
3

Team · 16 people

from the firm's website & public directories
Brian Belsky· General Partner
Amar Sawhney· Advisor, PhD
Clayton Gentsch· Operating Partnerin
Eric Leuthardt· Advisor, MD, MBA
Gregory J. Della Rocca· Advisor, MD, PhD, MBA
Janet Rader· Advisor, MD
Jason Wright· Advisor, MD
John Matthew Felder· Advisor, MD
Ling Liu· Advisor, PhD
Mira Aubuchon· Advisor, MD
Neill Li· Advisor, MD
Pat Geraghty· Advisor, MD
Rob Kill· Advisor
Thy Huskey· Advisor, MD
Tina Mahajan· Advisor, MD, MBA

What they invest in

from 1 of 3 portfolio companies

Biotech ×1FemTech ×1Healthtech ×1Medical Devices ×1

HQs:United States×1

Investments · 3 tracked

founders shown can be your intro path
Rejonirejoni.cominSep 2020

Rejoni is a company focused on uterine health, developing technology to address women's reproductive and gynecological health needs.

BiotechFemTechHealthtechMedical DevicesBedford, US

AMARPREET SAWHNEY(Executive Officer, Director, Promoter)inAmar Sawhney(Founder)inNICK SVENCER(Executive Officer, Director, Promoter)FARHAD KHOSRAVI(Executive Officer, Director, Promoter)

BoardTARA BUTLER(Executive Officer, Director, Promoter)

Co-investorsAscension VenturesClavystBioDelos CapitalFemHealth VenturesAmed VenturesCatalyst Health Ventures

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Kandu, Inc.Tulavi

Portfolio news

latest coverage across their companies

Frequently asked questions

What stage does Iyengar Capital Partners invest at?
Iyengar Capital Partners invests at the Seed, Series A, Series B stages.
What sectors does Iyengar Capital Partners focus on?
Iyengar Capital Partners focuses on Healthtech, Medical Devices.
Where is Iyengar Capital Partners located?
Iyengar Capital Partners is headquartered in Clayton, US.
Who does Iyengar Capital Partners co-invest with?
Iyengar Capital Partners most often shares deals with Ascension Ventures, ClavystBio, Delos Capital, among 4 tracked co-investors.

Similar investors

Featured in lists